Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Aurelius Health Group vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.2

Aurelius Health Group

Best for Buyers specifically seeking a transparent, care-inclusive compounded-tirzepatide MICRODOSING program who understand that microdosing has a more limited evidence base and likely smaller weight-loss effect than standard full-dose therapy. Not for buyers wanting maximum-efficacy full-dose GLP-1 treatment. Verify state availability, pharmacy sourcing, and clinical oversight directly.
★★★☆☆3.1

Starting at $89/mo

Compounded tirzepatide MICRODOSING protocol (dual GIP + GLP-1, low-dose)Transparent published pricing: $89 first month, then $199/monthPrice includes physician consults, full protocol, shipping, monthly check-ins, secure messaging, HIPAA platformStackable add-ons: NAD+, L-carnitine, B12, or inositol
Visit Aurelius Health Group
8.7

Vytora Health

Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
★★★★4.4

Starting at $150/mo

CompoundedBrand-Name Available (Mounjaro + Zepbound)All 50 States + DCLegitScript Approved
Visit Vytora Health

Side-by-Side Comparison

FeatureAurelius Health GroupVytora Health
Overall Score6.2/108.7/10
Starting Price$89/mo$150/mo
Editorial Rating3.1 ★ /54.4 ★ /5
Features6 features10 features
States Available051
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Aurelius Health Group

Pros

  • Pricing is fully published and bundled ($89 first month / $199/mo all-in) — more transparent than many compounded-GLP-1 DTC brands
  • LegitScript-certified seal displayed
  • Care-inclusive model (consults + monthly monitoring + secure messaging) rather than transactional Rx-only
  • Unusually candid about the limited evidence base for microdosing

Cons

  • MICRODOSE-only model — sub-therapeutic doses have a thinner RCT evidence base than the FDA-approved full-dose tirzepatide regimen (the site acknowledges this); expect smaller weight-loss effect than standard dosing
  • No semaglutide / standard full-dose option disclosed
  • No named compounding pharmacy partner
  • No specific state list and no named medical director / PIC disclosed
  • LegitScript ID number not captured at verification (seal present)

Vytora Health

Pros

  • All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
  • Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
  • LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
  • Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
  • Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
  • Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
  • Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens

Cons

  • Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
  • Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
  • Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
  • Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
  • Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)

Our Verdict

Winner: Vytora HealthScore: 8.7/10

Vytora Health edges out Aurelius Health Group with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. Aurelius Health Group remains a solid alternative, especially if you're looking for Buyers specifically seeking a transparent, care-inclusive compounded-tirzepatide MICRODOSING program who understand that microdosing has a more limited evidence base and likely smaller weight-loss effect than standard full-dose therapy. Not for buyers wanting maximum-efficacy full-dose GLP-1 treatment. Verify state availability, pharmacy sourcing, and clinical oversight directly..

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Aurelius Health Group and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.